Zhongping X. Cheng

197 Ruijin 2nd Road
Huangpu, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Duo Nang Decoction enhances endometrial receptivity in PCOS rats by upregulating caveolin-1 expression.

Duo Nang Decoction enhances endometrial receptivity in PCOS rats by upregulating caveolin-1 expression.

Journal: Pakistan journal of pharmaceutical sciences

Published: August 22, 2026

Iron-lipid crosstalk in the progression from gestational diabetes to preeclampsia: proteomic discovery and targeted validation.

Iron-lipid crosstalk in the progression from gestational diabetes to preeclampsia: proteomic discovery and targeted validation.

Journal: American journal of translational research

Published: March 10, 2026

Spherical petal-like ZnO-NiO p-n junction as an excellent ROS scavenger to inhibit the proliferation and migration of ovarian cancer cells.

Spherical petal-like ZnO-NiO p-n junction as an excellent ROS scavenger to inhibit the proliferation and migration of ovarian cancer cells.

Journal: Nanoscale

Published: February 04, 2026

Nanocrystalline berberine is associated with improved antitumor activity of PD-1 blockade in ovarian cancer.

Nanocrystalline berberine is associated with improved antitumor activity of PD-1 blockade in ovarian cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 02, 2025

Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.

Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.

Journal: Journal of translational medicine

Published: November 24, 2025

PiggyBac-engineered membrane-bound IL-7 TILs combined with anti-PD-1 antibody demonstrates efficacy in recurrent ovarian cancer: a first-in-human phase 1 trial.

PiggyBac-engineered membrane-bound IL-7 TILs combined with anti-PD-1 antibody demonstrates efficacy in recurrent ovarian cancer: a first-in-human phase 1 trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 29, 2025

PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti-PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial.

PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti-PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 29, 2025

Removal of the "dog-ear" during laparoscopic anterior resection with double stapling technique reduces the anastomotic leakage: a prospective cohort study.

Removal of the "dog-ear" during laparoscopic anterior resection with double stapling technique reduces the anastomotic leakage: a prospective cohort study.

Journal: Techniques in coloproctology

Published: February 20, 2025

Single-cell RNA sequencing reveals tumor microenvironment characteristics in ovarian malignant Brenner tumor.

Single-cell RNA sequencing reveals tumor microenvironment characteristics in ovarian malignant Brenner tumor.

Journal: Genes & diseases

Published: December 09, 2024

SF3a1: A Novel Potential Tumor Biomarker or Therapeutic Target.

SF3a1: A Novel Potential Tumor Biomarker or Therapeutic Target.

Journal: Journal of Cancer

Published: December 01, 2024

Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells.

Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells.

Journal: Translational oncology

Published: September 09, 2024

Exploring the Potential Value of Modulation of Cell Death in Immunotherapy of Gynecological Tumors.

Exploring the Potential Value of Modulation of Cell Death in Immunotherapy of Gynecological Tumors.

Journal: Gynecology and minimally invasive therapy

Published: August 01, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026